Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome ; volume:13 ; number:4 ; day:28 ; month:3 ; year:2012 ; pages:1-12 ; date:12.2012
BMC bioinformatics ; 13, Heft 4 (28.3.2012), 1-12, 12.2012
- Urheber
-
Cornero, Andrea
- Beteiligte Personen und Organisationen
-
Acquaviva, Massimo
Fardin, Paolo
Versteeg, Rogier
Schramm, Alexander
Eva, Alessandra
Bosco, Maria Carla
Blengio, Fabiola
Barzaghi, Sara
Varesio, Luigi
SpringerLink (Online service)
- DOI
-
10.1186/1471-2105-13-S4-S13
- URN
-
urn:nbn:de:1111-2016021737950
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cornero, Andrea
- Acquaviva, Massimo
- Fardin, Paolo
- Versteeg, Rogier
- Schramm, Alexander
- Eva, Alessandra
- Bosco, Maria Carla
- Blengio, Fabiola
- Barzaghi, Sara
- Varesio, Luigi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Artificial neural network classifier predicts neuroblastoma patients’ outcome
An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma
Predicting clinical outcome of neuroblastoma patients using an integrative network-based approach
Multiple classifier applied on predicting microsleep from speech
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature
A 6-gene signature identifies four molecular subgroups of neuroblastoma
Predicting breast cancer using an expression values weighted clinical classifier
Predicting clinical outcomes in neuroblastoma with genomic data integration
Development and validation of a 21-gene prognostic signature in neuroblastoma
Radiomics analysis of contrast-enhanced computed tomography in predicting the International Neuroblastoma Pathology Classification in neuroblastoma
Artificial neural network classifier predicts neuroblastoma patients’ outcome
An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma
Predicting clinical outcome of neuroblastoma patients using an integrative network-based approach
Multiple classifier applied on predicting microsleep from speech
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature
A 6-gene signature identifies four molecular subgroups of neuroblastoma
Predicting breast cancer using an expression values weighted clinical classifier
Predicting clinical outcomes in neuroblastoma with genomic data integration
Development and validation of a 21-gene prognostic signature in neuroblastoma
Radiomics analysis of contrast-enhanced computed tomography in predicting the International Neuroblastoma Pathology Classification in neuroblastoma
Artificial neural network classifier predicts neuroblastoma patients’ outcome
An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma
Predicting clinical outcome of neuroblastoma patients using an integrative network-based approach
Multiple classifier applied on predicting microsleep from speech
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature
A 6-gene signature identifies four molecular subgroups of neuroblastoma
Predicting breast cancer using an expression values weighted clinical classifier
Predicting clinical outcomes in neuroblastoma with genomic data integration
Development and validation of a 21-gene prognostic signature in neuroblastoma